Author

Qiuping Lin

Shanghai Jiao Tong University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Assay:scRNA-seq· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Ang LiiD· 1 shared Dan Li· 1 shared Hui Weng· 1 shared Jia‐Qi LuoiD· 1 shared Jiamin ZhaniD· 1 shared Lianni Mei· 1 shared Libing Shen· 1 shared Lijian XieiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Ang LiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Delineation of Single-cell Altas Provides New Insights for Development of Coronary Artery Lesions in Kawasaki Disease: Bad and Good Signaling Molecules

Qiuping Lin, Xin Lv, Qingzhu Qiu, Lianni Mei, Liqin Chen, Sirui Song, Wei Xin Liu, Xunwei Jiang, Min Huang, Libing Shen, Tingting Xiao, Lijian Xie

This study uses single-cell RNA sequencing to identify dysregulated signaling molecules in Kawasaki Disease patients with and without coronary artery lesions.

Frontiers in Pediatrics · Jun 25, 2025Peer-reviewedImmunology

Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers

Ang Li, Yi Zi, Jia‐Qi Luo, Xiaobin You, Zhaoji Lan, Tianliangwen Zhou, Yangming Wu, Qihuan Zhi, Sun Gang, Mei Zhu, Siwen Xu, Yun Gao, Zaixuan Zhong, Ling Xie, Yuanqin Wang, , Yujian Shi

This study identifies Chinese-specific BRCA1/2 mutation-associated cancer risk regions and characterizes mutation penetrance in a Chinese population.

Journal of Oncology · Mar 26, 2022Peer-reviewedGenetic & Genomic Medicine